We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Newgen BioPharma Corporation (CE) | USOTC:NEWG | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
Nevada
|
N/A
|
|
(State or other jurisdiction
|
(IRS Employer Identification No.)
|
|
of Incorporation or organization)
|
|
3221 Dominquez Avenue, Quezon City, Philippines
|
(Address of principal executive offices and zip code)
|
844-624-4793
|
(Registrant's telephone number, including area code)
|
☐
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☒
|
Smaller Reporting company
|
Class
|
|
Outstanding at March 11, 2015
|
Common stock, $0.001 par value
|
|
11,900,000
|
|
|
Page
|
|
|
|
|
|
|
Item 1.
|
4
|
|
|
|
|
Item 2.
|
13
|
|
|
|
|
Item 3.
|
17
|
|
|
|
|
Item 4.
|
17
|
|
|
|
|
|
|
|
Item 1.
|
18
|
|
|
|
|
Item 1A.
|
18
|
|
|
|
|
Item 2.
|
18
|
|
|
|
|
Item 3.
|
18
|
|
|
|
|
Item 4.
|
18
|
|
|
|
|
Item 5.
|
18
|
|
|
|
|
Item 6.
|
19
|
|
|
|
|
20
|
ASSETS
|
January 31,
2015
(unaudited)
|
October 31,
2014
|
||||||
Current Assets
|
||||||||
Cash and cash equivalents
|
$
|
0
|
$
|
0
|
||||
Total Current Assets
|
0
|
0
|
||||||
TOTAL ASSETS
|
$
|
0
|
$
|
0
|
||||
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
Liabilities
|
||||||||
Current Liabilities
|
||||||||
Accounts payable and accrued liabilities
|
$
|
14,404
|
$
|
13,678
|
||||
Notes payable – related party
|
45,686
|
36,237
|
||||||
Total Liabilities
|
60,090
|
49,915
|
||||||
Stockholders' Deficit
|
||||||||
Common stock, par $0.001, 75,000,000 shares authorized, 11,900,000 shares issued and outstanding
|
11,900
|
11,900
|
||||||
Additional paid in capital
|
53,477
|
53,477
|
||||||
Accumulated deficit
|
(125,467
|
)
|
(115,292
|
)
|
||||
Total Stockholders' Deficit
|
(60,090
|
)
|
(49,915
|
)
|
||||
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
|
$
|
0
|
$
|
0
|
Three months ended
January 31,
2015
|
Three months ended
January 31,
2014
|
|||||||
GROSS REVENUES
|
$
|
0
|
$
|
0
|
||||
OPERATING EXPENSES
|
||||||||
Professional fees
|
8,621
|
18,159
|
||||||
Website design
|
0
|
0
|
||||||
Depreciation
|
0
|
0
|
||||||
General and administrative
|
1,554
|
1,728
|
||||||
TOTOAL OPERATING EXPENSES
|
10,175
|
19,887
|
||||||
LOSS FROM OPERATIONS
|
(10,175
|
)
|
(19,887
|
)
|
||||
OTHER EXPENSES
|
0
|
0
|
||||||
NET LOSS BEFORE INCOME TAXES
|
(10,175
|
)
|
(19,887
|
)
|
||||
PROVISION FOR INCOME TAXES
|
0
|
0
|
||||||
NET LOSS
|
$
|
(10,175
|
)
|
$
|
(19,887
|
)
|
||
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED
|
11,900,000
|
11,900,000
|
||||||
NET LOSS PER SHARE: BASIC AND DILUTED
|
$
|
(0.00
|
)
|
$
|
(0.00
|
)
|
Three months ended
January 31,
2015
|
Three months ended
January 31,
2014
|
|||||||
Cash Flows from Operating Activities:
|
||||||||
Net loss
|
$
|
(10,175
|
)
|
$
|
(19,887
|
)
|
||
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
|
||||||||
Depreciation
|
0
|
0
|
||||||
Changes in Assets and Liabilities
|
||||||||
Increase (decrease) in accounts payable and accrued liabilities
|
726
|
17,925
|
||||||
Net Cash Used in Operating Activities
|
(9,449
|
)
|
(1,962
|
)
|
||||
Cash Flows from Investing Activities
|
||||||||
Purchase of property and equipment
|
0
|
0
|
||||||
Net Cash Used in Investing Activities
|
0
|
0
|
||||||
Cash Flows from Financing Activities:
|
||||||||
Proceeds from notes payable – related party
|
9,449
|
1,962
|
||||||
Proceeds from the sale of common stock
|
0
|
0
|
||||||
Net Cash Provided by Financing Activities
|
9,449
|
1,962
|
||||||
Net Increase (Decrease) in Cash and Cash Equivalents
|
0
|
0
|
||||||
Cash and Cash Equivalents – Beginning
|
0
|
0
|
||||||
Cash and Cash Equivalents – Ending
|
$
|
0
|
$
|
0
|
||||
Supplemental Cash Flow Information:
|
||||||||
Cash paid for interest
|
$
|
0
|
$
|
0
|
||||
Cash paid for income taxes
|
$
|
0
|
$
|
0
|
January 31,
2015
|
October 31,
2014
|
|||||||
Legal
|
$
|
6,104
|
$
|
3,678
|
||||
Audit
|
1,750
|
5,000
|
||||||
Accounting
|
5,000
|
3,750
|
||||||
Edgarizing
|
1,550
|
1,250
|
||||||
Total Accrued Expenses
|
$
|
14,404
|
$
|
13,678
|
(a)
|
As at January 31, 2015, the Company owed $45,686 (October 31, 2014 - $36,237) to the President and Director of the Company for loans made to the Company for working capital. The amounts owing are unsecured, non-interest bearing, and due on demand.
|
Gross Proceeds
|
$
|
100,000.00
|
||
Offering Expense
|
$
|
20,000.00
|
||
Net Proceeds
|
$
|
100,000.00
|
||
Net Proceeds to be used
|
||||
Inventory
|
$
|
40,000.00
|
||
Website development
|
$
|
5,000.00
|
||
Marketing and Advertising
|
$
|
20,000.00
|
||
Audit, Accounting and filing Fees
|
$
|
10,000.00
|
||
Working Capital
|
$
|
17,217.00
|
||
Repayment of accounts payable and accrued liabilities
|
$
|
7,783.00
|
Description
|
Price
|
||
5KW (complete kits for 5KW off grid wind generator system with free standing tower)
|
US$10,812
|
||
2KW (complete kits for 5KW off grid wind generator system with free standing tower)
|
US$3,405
|
||
500W (complete kits for 500W off grid wind generator system with guyed tower)
|
US$805
|
1.
|
$25,000 in connection with our development of our website and marketing efforts; and
|
|
|
||
2.
|
$10,000 for operating expenses, including professional legal and accounting expenses associated with our company being a reporting issuer under the Securities Exchange Act of 1934.
|
Exhibit
|
|
Description
|
No.
|
|
|
3.1
|
Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1 filed on December 23, 2011).
|
|
3.2
|
Bylaws (incorporated by reference to our Registration Statement on Form S-1 filed on December 23, 2011).
|
|
31.1*
|
|
|
31.2*
|
||
|
|
|
32.1*
|
|
|
32.2*
|
||
101*
|
Interactive Data Files
|
|
GREENWIND NRG INC.
|
|
|
|
|
Dated: March 13, 2015
|
By:
|
/s/ Jerwin Alfiler
|
Name:
|
Jerwin Alfiler
|
|
Title:
|
President, Secretary, Treasurer and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Greenwind NRG Inc. for the period ended January 31, 2015;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
|
4.
|
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
|
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c.
|
Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
|
|
d.
|
Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and
|
5.
|
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):
|
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and
|
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.
|
|
Date: March 13, 2015
|
|
|
|
|
|
By:
|
/s/ Jerwin Alfiler
|
|
Name:
|
Jerwin Alfiler
|
|
Title:
|
President, Secretary, Treasurer and Director (Principal Executive Officer)
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Greenwind NRG Inc. for the period ended January 31, 2015;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
|
4.
|
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
|
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c.
|
Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
|
|
d.
|
Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and
|
5.
|
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):
|
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and
|
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.
|
|
Date: March 13, 2015
|
|
|
|
|
|
By:
|
/s/ Jerwin Alfiler
|
|
Name:
|
Jerwin Alfiler
|
|
Title:
|
President, Secretary, Treasurer and Director (Principal Financial Officer and Principal Accounting Officer)
|
Date: March 13, 2015
|
||
|
||
By:
|
/s/ Jerwin Alfiler
|
|
Name:
|
Jerwin Alfiler
|
|
Title:
|
President, Secretary, Treasurer and Director (Principal Executive Officer)
|
Date: March 13, 2015
|
||
|
||
By:
|
/s/ Jerwin Alfiler
|
|
Name:
|
Jerwin Alfiler
|
|
Title:
|
President, Secretary, Treasurer and Director (Principal Financial Officer and Principal Accounting Officer)
|
1 Year Newgen BioPharma (CE) Chart |
1 Month Newgen BioPharma (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions